CDE Announcement: Updated Guidelines for Pediatric Medicines! “Technical Guidance on the Application of Physiologically Based Pharmacokinetic Models in Drug Development for Pediatric Populations (Draft for Public Comment)”
2024-10-27
8 month 17 Day, CDE A notice has been issued soliciting public comments on the “Technical Guidance Principles for the Application of Physiologically Based Pharmacokinetic Models in Drug Development for Pediatric Populations (Draft for Comments).” The drafting of these guidance principles has been underway since… 2021 year 10 The initiative was launched as early as this month, primarily focusing on the drug development process for pediatric populations. PBPK The relevant aspects of model application are elaborated, and recommendations are provided for the standardized use of such models. The main content covers the application of modeling in pediatric drug development, model implementation and evaluation, as well as format and submission requirements, along with a discussion section.
The revised guiding principles also follow… 2017 the “Technical Guidance Principles for Extrapolating Adult Drug Data to the Pediatric Population” issued in [year], as well as 2022 year 4 Monthly solicitation of ICH 《 E11A : Following the “Pediatric Extrapolation” guideline, this is another set of guidance on the application of modeling data in pediatric clinical practice. The relevant content is outlined below—let’s take a brief look!
The overall guiding principles give the impression that, PBPK The ultimate goal of modeling is to streamline clinical trials. , and assist in designing the corresponding experimental protocol. , Supports regulatory decision-making , Accelerating the drug development process and promoting rational pediatric use in clinical practice , However, this does not mean that modeling alone is sufficient to obviate the need for clinical work; rather, pediatric clinical data are still required to validate the model to a certain extent.
Keywords：
Related information
2026-08-04
2024-10-27
2026-07-03
Please contact us for more detailed information.
Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!
Follow us
Nanjing Kangchuanji Pharmatech Co., Ltd.
Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）
Copyright © Nanjing Kangchuanji Pharmatech Co., Ltd.